Jie Wu

Jie Wu

Auto-generated profile, based on publicly available information

Jie Wu

State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2023 in eClinicalMedicine
Verified
Journal Article
Open access
PLPeizhao Liu
Peizhao Liu
SLSicheng Li
Sicheng Li
TZTao Zheng
Tao Zheng
JWJie Wu
Jie Wu
YFYong Fan
Yong Fan
RJRen Jian'an
Ren Jian'an
The great heterogeneity of patients with chronic critical illness (CCI) leads to difficulty for intensive care unit (ICU) management. Identifying subphenotypes could assist in individualized care, which has not yet been explored. In this study, we aim to identify the subphenotypes of patients with CCI and reveal the heterogeneous treatment effect of fluid balance for them. In this retrospective study, we defined CCI as an ICU length of stay over 14 days and coexists with persistent organ dysfunction (cardiovascular Sequential Organ Failure Assessment (SOFA) score ≥1 or score in any other organ system ≥2) at Day 14. Data from five electronic healthcare record datasets covering geographically distinct populations (the US, Europe, and China) were studied. These five datasets include (1) subset of Derivation (MIMIC-IV v1.0, US) cohort (2008–2019); (2) subset Derivation (MIMIC-III v1.4 ‘CareVue’, US) cohort (2001–2008); (3) Validation I (eICU-CRD, US) cohort (2014–2015); (4) Validation II (AmsterdamUMCdb/AUMC, Euro) cohort (2003–2016); (5) Validation III (Jinling, CN) cohort (2017–2021). Patients who meet the criteria of CCI in their first ICU admission period were included in this study. Patients with age over 89 or under 18 years old were excluded. Three unsupervised clustering algorithms were employed independently for phenotypes derivation and validation. Extreme Gradient Boosting (XGBoost) was used for phenotype classifier construction. A parametric G-formula model was applied to estimate the cumulative risk under different daily fluid management strategies in different subphenotypes of ICU mortality. We identified four subphenotypes as Phenotype A, B, C, and D in a total of 8145 patients from three countries. Phenotype A is the mildest and youngest subgroup; Phenotype B is the most common group, of whom patients showed the oldest age, significant acid-base abnormality, and low white blood cell count; Patients with Phenotype C have hypernatremia, hyperchloremia, and hypercatabolic status; and in Phenotype D, patients accompany with the most severe multiple organ failure. An easy-to-use classifier showed good effectiveness. Phenotype characteristics showed robustness across all cohorts. The beneficial fluid balance threshold intervals of subphenotypes were different. We identified four novel phenotypes that revealed the different patterns and significant heterogeneous treatment effects of fluid therapy within patients with CCI. A prospective study is needed to validate our findings, which could inform clinical practice and guide future research on individualized care. This study was funded by 333 High Level Talents Training Project of 10.13039/501100002949 Jiangsu Province (BRA2019011), General Program of Medical Research from the Jiangsu Commission of Health (M2020052), and Key Research and Development Program of Jiangsu Province (BE2022823).

17 November 2022 in Frontiers in Public Health
Verified
Journal Article
Open access
TYTenglong Yan
Tenglong Yan
FJFang Ji
Fang Ji
MBMingli Bi
Mingli Bi
HWHuining Wang
Huining Wang
XCXueting Cui
Xueting Cui
XDXiaowen Ding
Xiaowen Ding
Objective: Occupational stress is a critical global public health problem. We aimed to evaluate the prevalence of occupational stress among the workers in the electricity, heat, gas, water production and supply (EHGWPS), manufacturing, and transportation industries in Beijing, China. We explored the demographic differences in occupational stress status among workers in industrial enterprises.Methods: A cross-sectional study was conducted on 13,867 workers. The self-administered New Brief Job Stress Questionnaire was used to evaluate high occupational stress status, which includes four sub-dimensions (job stressors, stress response, social support, job stressors & social support). Multiple regression and logistic regression models were used to estimate the association between high occupational stress and the four occupational stress sub-dimensions with risk factors.Results: A total of 13,867 workers were included. The prevalence of high occupational stress was 3.3% in the EHGWPS industries, 10.3% in manufacturing, and 5.8% in transportation. The prevalence of high occupational stress was higher than in the other two categories (p < 0.05) in manufacturing industries. Logistic regression analysis showed that male workers with lower educational status, more job experience, and working in manufacturing were vulnerable to high occupational stress. Further analysis of the four occupational stress sub-dimensions showed that male workers, older adult workers, workers with lower educational levels, and longer working time were associated with higher scores in job stressors, stress response, social support, and job stress & social support (all p < 0.05). Moreover, divorced or widowed workers had higher occupational stress scores.Conclusion: Male workers with lower educational levels and longer working time may have an increased risk of occupational stress.

31 January 2026 in Therapeutic Advances in Gastroenterology
Verified
Journal Article
Open access
BCBaode Chen
Baode Chen
LZLuyan Zheng
Luyan Zheng
XHXuelin He
Xuelin He
JWJie Wu
Jie Wu
MZMin Zheng
Min Zheng
Background: Acute kidney injury (AKI) in cirrhotic patients is associated with high morbidity and mortality. Serum creatinine (sCr) has limited utility for early detection and etiological differentiation. Novel biomarkers and predictive models offer potential to address these limitations. Objectives: To comprehensively evaluate the diagnostic performance of novel biomarkers and predictive models for the early detection and etiological differentiation of AKI in patients with liver cirrhosis. Design: Systematic review conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Data sources and methods: A comprehensive literature search was performed in PubMed / Medline , EMBASE , and the Cochrane Library from inception to August 31, 2025. Studies evaluating biomarkers or models for AKI prediction or phenotyping in adult cirrhotic patients were included. Study selection, data extraction, and quality assessment (using Quality Assessment of Diagnostic Accuracy Studies-2, QUADAS-2) were performed independently by reviewers. Results: A total of 33 studies were included. For the early prediction of AKI, serum cystatin C (Cys C) demonstrated superior performance to sCr, with an area under the receiver operating characteristic curve (AUROC) of up to 0.85. Urinary neutrophil gelatinase-associated lipocalin (NGAL) exhibited strong predictive capability and was most reliable in differentiating acute tubular necrosis from hepatorenal syndrome (HRS), achieving an AUROC up to 0.87. In contrast, kidney injury molecule-1, interleukin-18, and liver-type fatty acid binding protein, showed only moderate or inconsistent performance across most studies. Seven studies developed predictive models by integrating clinical variables with biomarkers, some of which employed machine learning techniques. However, the clinical applicability of these models is currently constrained by significant heterogeneity and limited external validation. Conclusion: Serum Cys C and urinary NGAL offer distinct advantages over sCr in the early diagnosis and phenotypic differentiation of AKI. Although prediction models show promise, their routine clinical application requires further standardization and extensive external validation. Trial registration: PROSPERO (CRD420251126410).

1 November 2019 in Liver International
Verified
Journal Article
Closed access
PDF file
JWJie Wu
Jie Wu
HWHong‐Liang Wang
Hong‐Liang Wang
XLXiaoxiao Liu
Xiaoxiao Liu
CDCheng Ding
Cheng Ding
YZYuqing Zhou
Yuqing Zhou
SYShigui Yang
Shigui Yang


3 November 2026 in Journal of Medical Internet Research
Verified
Journal Article
Open access
HYHaolan Yu
Haolan Yu
LJLiehao Jiang
Liehao Jiang
ZTZhuo Tan
Zhuo Tan
JWJie Wu
Jie Wu
MGMinghua Ge
Minghua Ge
Head and neck squamous cell carcinoma (HNSCC) represents a significant public health challenge. Its treatment is characterized by high anatomical complexity and a critical need for functional preservation of speech, swallowing, and respiration. While multimodality care, including surgery, radiotherapy, and systemic therapy, has substantially improved patient survival, there are still high rates of life-altering toxicities and low response rates to immunotherapy. Current clinical decision-making largely relies on “digital snapshots”—static representations derived from population-based statistics and time point–specific imaging—which usually fail to account for the rapid anatomical and biological change during the course of treatment. Digital twins hold great promise in accelerating scientific breakthroughs and transforming oncology treatment and precision medicine through the creation of high-fidelity virtual patient representations that integrate real-time biological, anatomical, and clinical data. In this viewpoint, we propose 3 interconnected digital twins to establish a conceptual framework for the HNSCC digital twin. These digital twins include the anatomical twin, using virtual surgical planning and augmented reality for geometric precision; the dosimetric twin, using daily imaging and synthetic computed tomography generation for automated adaptive radiotherapy; and the biological twin, integrating deep phenotyping, radiomics, and mechanistic omics to simulate individualized therapeutic trajectories. Beyond acute care, we explore the clinical utility of digital twins in navigating the “de-escalation dilemma” for human papillomavirus–associated disease and improving survivorship through digital phenotyping. With the advent of longitudinal data from medical-grade Internet-of-Things sensors and circulating tumor DNA kinetics, digital twins can serve as active sentinels, detecting functional decline or subclinical events months before clinical manifestation. Furthermore, the implementation of synthetic control arms via virtual populations offers an avenue to accelerate clinical trials and address ethical issues in rare molecular subtypes. Despite this potential, substantial barriers to implementation remain, including profound anatomical instability during treatment, the “black box” nature of deep learning algorithms, and the challenges of multiscale data integration. We provide a technical roadmap for the development of “morphing” digital twins—dynamic systems capable of continuous geometric and biological auditing. By bridging the gap between the macroscopic world of radiation physics and the microscopic world of cellular evolution, digital twins may help shift the management of HNSCC from population-based statistical probability toward more individualized, biologically informed decision-making, with the goal of optimizing HNSCC management while preserving essential patient functions.